Prof Hagemeyer is a Senior Research Fellow of the NHMRC and Head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases (Monash University). He studied Chemistry in Germany and obtained a PhD in Biochemistry from the University of Freiburg (Germany) for contributions to the field of Cytochrome P450 metabolism in the brain. As a postdoctoral fellow, he worked in the field of Magnetic Resonance Imaging (MRI) at the “Centre national de la recherche scientifique” in Bordeaux (France) before migrating to Australia in 2005. He has particular expertise in the use of small recombinant single-chain antibodies for molecular imaging and drug delivery. He has work extensively in cardiovascular research developing anti-thrombotic fusion proteins and novel imaging probes for MRI, Ultrasound and Positron Emission Tomography. He has published widely in leading journals (Circ Res, Adv Mater, Angew Chem..) on vascular biology, molecular imaging, recombinant antibodies and nanotechnology and has been supported throughout his career by national and international fellowships and grants.
NIF is hiring: As the Scientific Project Manager, you will be instrumental in driving the successful delivery of key initiatives within the National Imaging Facility.
10 September 2024
The groundbreaking Australian Mild Traumatic Brain Injury (AUS-mTBI) study will see thousands of volunteers from across the country who have had a recent concussion have the option to opt-in to repo
01 August 2024
16 March 2024
The Commonwealth Government Department of Education has today announced National Imaging Facility (NIF) will receive $28m under the National Collaborative Research Infrastructure Strategy (NCRIS), to
19 October 2023